Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC.

Subjects

Subjects :

Antineoplastic Agents pharmacology
Carcinoma, Non-Small-Cell Lung pathology
Cardiomyopathies pathology
Female
Gefitinib pharmacology
Humans
Lung Neoplasms pathology
Middle Aged
Mutation
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung complications
Cardiomyopathies chemically induced
Gefitinib therapeutic use
Lung Neoplasms complications

Details

Language :

English

ISSN :

1556-1380

Volume :

13

Issue :

10

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Report

Accession number :

30244856

Full Text :

https://doi.org/10.1016/j.jtho.2018.05.020